Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meir Goldsmith

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Nanomedicine (London, England)|November 30, 2011
Grand challenges in modulating the immune response with RNAi nanomedicinesMeir Goldsmith, Shoshy Mizrahy, Dan Peer
ACS Nano|March 26, 2014
Precision nanomedicine in neurodegenerative diseasesMeir Goldsmith, Lilach Abramovitz, Dan Peer
Nanotechnology|November 22, 2011
Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approachLeonardo J Solmesky, Michal Shuman, Meir Goldsmith, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 7, 2021
Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian CancerManu Smriti Singh, Srinivas Ramishetti, Dalit Landesman-Milo, et al.
Molecular Immunology|April 14, 2009
Synergistic IL-10 induction by LPS and the ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathwaysMeir Goldsmith, Dorit Avni, Orna Ernst, et al.
ACS Nano|January 7, 2015
Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticlesZvi R Cohen, Srinivas Ramishetti, Naama Peshes-Yaloz, et al.
Nature Communications|October 31, 2018
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytesNuphar Veiga, Meir Goldsmith, Yasmin Granot, et al.
Nature Nanotechnology|June 18, 2021
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeuticsNiels Dammes, Meir Goldsmith, Srinivas Ramishetti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2019
Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory targetNuphar Veiga, Meir Goldsmith, Yael Diesendruck, et al.
Journal of the American Chemical Society|February 21, 2012
Nanoparticle hydrophobicity dictates immune responseDaniel F Moyano, Meir Goldsmith, David J Solfiell, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Nanomedicine (London, England)|November 30, 2011
Grand challenges in modulating the immune response with RNAi nanomedicinesMeir Goldsmith, Shoshy Mizrahy, Dan Peer
ACS Nano|March 26, 2014
Precision nanomedicine in neurodegenerative diseasesMeir Goldsmith, Lilach Abramovitz, Dan Peer
Nanotechnology|November 22, 2011
Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approachLeonardo J Solmesky, Michal Shuman, Meir Goldsmith, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 7, 2021
Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian CancerManu Smriti Singh, Srinivas Ramishetti, Dalit Landesman-Milo, et al.
Molecular Immunology|April 14, 2009
Synergistic IL-10 induction by LPS and the ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathwaysMeir Goldsmith, Dorit Avni, Orna Ernst, et al.
ACS Nano|January 7, 2015
Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticlesZvi R Cohen, Srinivas Ramishetti, Naama Peshes-Yaloz, et al.
Nature Communications|October 31, 2018
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytesNuphar Veiga, Meir Goldsmith, Yasmin Granot, et al.
Nature Nanotechnology|June 18, 2021
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeuticsNiels Dammes, Meir Goldsmith, Srinivas Ramishetti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2019
Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory targetNuphar Veiga, Meir Goldsmith, Yael Diesendruck, et al.
Journal of the American Chemical Society|February 21, 2012
Nanoparticle hydrophobicity dictates immune responseDaniel F Moyano, Meir Goldsmith, David J Solfiell, et al.
Pageof 4